Skip to main content
. 2018 Apr 23;13(4):e0196023. doi: 10.1371/journal.pone.0196023

Table 3. The correlation matrix of inter-subset for the first-episode drug naive MDD patients.

First-episode drug naive group
(n = 36)
DET
(n = 33
IDN
(n = 36)
OCL
(n = 35)
TWOB
(n = 36)
GML
(n = 34)
ISL
(n = 36)
SEC
(n = 35)
CPAL
(n = 34)
Composite
(n = 36)
HAMD
(n = 29)
Pearson Correlation 0.085 0.294 -0.415* -0.218 0.230 -0.265 -0.352 0.302 -0.227
Sig. (2-tailed) 0.680 0.122 0.028 0.256 0.249 0.164 0.061 0.126 0.237
HAMA
(n = 29)
Pearson Correlation 0.173 0.238 -0.376* -0.236 0.109 -0.129 -0.381* 0.112 -0.268
Sig. (2-tailed) 0.398 0.214 0.049 0.217 0.588 0.504 0.041 0.578 0.160
MADRS
(n = 29)
Pearson Correlation 0.166 0.136 -0.202 -0.268 -0.061 -0.177 -0.293 0.397* -0.215
Sig. (2-tailed) 0.418 0.483 0.303 0.160 0.762 0.358 0.123 0.041 0.263
QOL
(n = 29)
Pearson Correlation -0.388* -0.055 0.085 -0.212 0.160 0.154 -0.079 -0.057 -0.080
Sig. (2-tailed) 0.050 0.776 0.667 0.269 0.424 0.426 0.685 0.776 0.680
SASS
(n = 29)
Pearson Correlation -0.223 0.041 -0.023 -0.164 0.001 0.027 -0.254 0.089 -0.140
Sig. (2-tailed) 0.272 0.832 0.907 0.394 0.995 0.889 0.183 0.660 0.470
CWRT
(n = 29)
Pearson Correlation -0.077 -0.261 -0.028 0.073 -0.083 0.323 0.199 -0.425* -0.010
Sig. (2-tailed) 0.708 0.171 0.888 0.708 0.681 0.088 0.302 0.027 0.958

*p<0.05